Back to top
Rydex Series Trust Biotechnology Fund Investor Class: (MF: RYOIX)
(NASDAQ Mutual Funds) As of Jan 30, 2026 05:30 PM ET
$76.42 USD
-0.68 (-0.88%)
Zacks MF Rank
4-Sell of 5 4
Latest Performance as of Dec 31, 2025
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | 30.73 | 15 |
| 3 months | 15.24 | 35 |
| 6 months | 32.68 | 15 |
| 1 Year | 30.74 | 15 |
| 3 Year | 11.24 | 28 |
| 5 Year | 4.03 | 62 |
| 10 Year | 5.86 | 90 |
* Annual for three years and beyond.
| Bull Market (9/02 - 10/07) | 93.40 |
| Bear Market (10/07 - 2/09) | -26.43 |
| Bull Market (2/09 - 3/21) | 796.04 |
Load Adjusted Returns as of Dec 31, 2025
| 1 Year | 30.73 |
| 5 Year | 4.02 |
| 10 Year | 5.86 |
| Since Inception | 10.75 |
Quarterly Return
| 1st Qtr. | 2nd Qtr. | 3rd Qtr. | 4th Qtr. | |
|---|---|---|---|---|
| 2025 | -1.34 | -0.12 | 15.14 | 15.24 |
| 2024 | 0.79 | 2.09 | 4.90 | -8.04 |
| 2023 | -2.19 | 0.10 | -3.84 | 12.65 |
| 2022 | -9.87 | -10.24 | -2.14 | 9.84 |
| 2021 | -1.55 | 10.07 | -3.17 | -2.97 |
Annual Return
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| % Total Return | 30.73 | -0.73 | 6.05 | -13.05 | 1.80 | 22.09 | 25.01 | -8.97 | 29.73 | -19.50 |
| % Total Return Rel to Index | 12.51 | -25.75 | -20.18 | 5.15 | -26.88 | 3.68 | -6.47 | -4.58 | 7.93 | -31.44 |
| % Total Return Rel to Peer | 10.07 | -3.34 | 0.29 | -3.63 | -6.88 | 0.81 | -1.67 | -9.10 | 7.61 | -8.72 |
| % Perf Quintile vs Peer* | 0.00 | 0.00 | 2.00 | 4.00 | 5.00 | 3.00 | 4.00 | 5.00 | 2.00 | 5.00 |
| % Dividends | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| % Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Gains ($) | 9.41 | 9.42 | 0.00 | 0.90 | 15.77 | 6.95 | 3.60 | 9.88 | 4.70 | 0.00 |
| Expense Ratio | 1.40 | 1.40 | 1.39 | 1.36 | 1.45 | 1.48 | 1.46 | 1.37 | 1.37 | 1.32 |
* 1 = Top 20%, 5 = Bottom 20%